Osteophyte development--molecular characterization of differentiation stages.
OBJECTIVE
Osteophytes are non-neoplastic osteo-cartilaginous protrusions growing at the margins of osteoarthritic joints. They can not only be considered as in situ repair tissue, but also represent an excellent in vivo model for induced cartilage repair processes. Our focus was to identify different steps of osteophyte development via analysis of expression patterns of marker genes of chondrocytic differentiation.


METHODS
We performed an extensive analysis of the presence and expression of matrix components using histochemical, immunohistochemical and in situ hybridization technology.


RESULTS
Four different stages of osteophyte formation could be identified based on histomorphological and cell biological parameters: starting from mesenchymal condensates, chondrogenic differentiation is indicated by the onset of Col2A and aggrecan expression (stage I). Stage II shows fibrocartilage with an admixture of cartilaginous and fibrous matrix components such as Col2 and aggrecan on the one hand and Col1 on the other hand. The proliferating osteophyte (stage III) shows a zonal organization similar to the fetal growth plate cartilage with extensive chondrocyte hypertrophy in the zones next to ongoing endochondral bone formation. 'Mature' osteophytes (stage IV) resembled largely articular hyaline cartilage with a predominance of Col2 and aggrecan and Col6 found mainly pericellularily.


CONCLUSIONS
The development of osteophytes is a good in vivo model to pursue chondrocyte differentiation from pluripotent mesenchymal cells to mature or hypertrophic chondrocytes in situ in the adult. The analysis of marker molecules of mesenchymal differentiation allows to identify different stages of repair tissue development and the transformation from fibrous tissue to neo-cartilage. Tissue architecture and matrix composition in mature osteophytes suggests that metaplastic neo-cartilagenous tissue might be one potential source of cartilage repair tissue in the adult joint.
Gelse
K
K
Cartilage Research, Department of Pathology, University of Erlangen-Nürnberg, Federal Republic of Germany.
Söder
S
S
Eger
W
W
Diemtar
T
T
Aigner
T
T
D000368:Aged; D000369:Aged, 80 and over; D053674:Aggrecans; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D019902:Chondrocytes / Q000473:pathology*; D003094:Collagen / Q000032:analysis; D005109:Extracellular Matrix / Q000473:pathology; D016326:Extracellular Matrix Proteins; D015870:Gene Expression; D005819:Genetic Markers; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization; D037181:Lectins, C-Type; D008875:Middle Aged; D010003:Osteoarthritis / Q000473:pathology*; D015207:Osteoarthritis, Hip / Q000473:pathology; D020370:Osteoarthritis, Knee / Q000473:pathology; D011509:Proteoglycans / Q000032:analysis
D053674:Aggrecans; D016326:Extracellular Matrix Proteins; D005819:Genetic Markers; D037181:Lectins, C-Type; D011509:Proteoglycans; D003094:Collagen